1 Judit Castillo‐Armengol, L. F., and Isabel C Lopez‐Mejia. Inter‐organ communication: a gatekeeper for metabolic health. EMBO reports 20: e47903 (2019).
2 Billman, G. E. Homeostasis: The Underappreciated and Far Too Often Ignored Central Organizing Principle of Physiology. Front Physiol 11, 200 (2020). https://doi.org/10.3389/fphys.2020.00200
3 Richter, E. A. & Hargreaves, M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 93, 993-1017 (2013). https://doi.org/10.1152/physrev.00038.2012
4 Cori, C. F. & Cori, G. T. Carbohydrate metabolism. Annu Rev Biochem 15, 193-218 (1946). https://doi.org/10.1146/annurev.bi.15.070146.001205
5 Parks, W. C., Wilson, C. L. & Lopez-Boado, Y. S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4, 617-629 (2004). https://doi.org/10.1038/nri1418
6 Fernandez-Patron, C., Kassiri, Z. & Leung, D. Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients. Compr Physiol 6, 1935-1949 (2016). https://doi.org/10.1002/cphy.c160010
7 Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67 (2010). https://doi.org/10.1016/j.cell.2010.03.015
8 Fernandez-Patron, C., Radomski, M. W. & Davidge, S. T. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 85, 906-911 (1999). https://doi.org/10.1161/01.res.85.10.906
9 Fernandez-Patron, C. et al. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 87, 670-676 (2000). https://doi.org/10.1161/01.res.87.8.670
10 Rodriguez, D., Morrison, C. J. & Overall, C. M. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta 1803, 39-54 (2010). https://doi.org/10.1016/j.bbamcr.2009.09.015
11 Serifova, X., Ugarte-Berzal, E., Opdenakker, G. & Vandooren, J. Homotrimeric MMP-9 is an active hitchhiker on alpha-2-macroglobulin partially escaping protease inhibition and internalization through LRP-1. Cell Mol Life Sci 77, 3013-3026 (2020). https://doi.org/10.1007/s00018-019-03338-4
12 Tchetverikov, I. et al. Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with alpha2 macroglobulin in serum of rheumatoid arthritis patients. Ann Rheum Dis 67, 128-130 (2008). https://doi.org/10.1136/ard.2006.067827
13 Sarker, H. et al. Identification of fibrinogen as a natural inhibitor of MMP-2. Sci Rep 9, 4340 (2019). https://doi.org/10.1038/s41598-019-40983-y
14 Wang, X. et al. MMP-2 inhibits PCSK9-induced degradation of the LDL receptor in Hepa1-c1c7 cells. FEBS Lett 589, 490-496 (2015). https://doi.org/10.1016/j.febslet.2015.01.007
15 Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T. & Liotta, L. A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265, 13933-13938 (1990).
16 Meng, Q. et al. Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate. J Biol Chem 274, 10184-10189 (1999). https://doi.org/10.1074/jbc.274.15.10184
17 Bigg, H. F., Shi, Y. E., Liu, Y. E., Steffensen, B. & Overall, C. M. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. J Biol Chem 272, 15496-15500 (1997). https://doi.org/10.1074/jbc.272.24.15496
18 Lindsey, M. L. Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling. Nat Rev Cardiol 15, 471-479 (2018). https://doi.org/10.1038/s41569-018-0022-z
19 Ouimet, M., Barrett, T. J. & Fisher, E. A. HDL and Reverse Cholesterol Transport. Circ Res 124, 1505-1518 (2019). https://doi.org/10.1161/CIRCRESAHA.119.312617
20 Filou, S. et al. Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function. Biochemistry 55, 3752-3762 (2016). https://doi.org/10.1021/acs.biochem.6b00389
21 Morgunova, E. et al. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 284, 1667-1670 (1999). https://doi.org/10.1126/science.284.5420.1667
22 Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583-589 (2021). https://doi.org/10.1038/s41586-021-03819-2
23 Kryshtafovych, A., Schwede, T., Topf, M., Fidelis, K. & Moult, J. Critical assessment of methods of protein structure prediction (CASP)-Round XIII. Proteins 87, 1011-1020 (2019). https://doi.org/10.1002/prot.25823
24 Richard Evans, M. O. N., Alexander Pritzel, Natasha Antropova, Andrew Senior, Tim Green, Augustin Žídek, Russ Bates, Sam Blackwell, Jason Yim, ProfileOlaf Ronneberger, Sebastian Bodenstein, Michal Zielinski, Alex Bridgland, Anna Potapenko, Andrew Cowie, Kathryn Tunyasuvunakool, Rishub Jain, Ellen Clancy, Pushmeet Kohli, John Jumper, Demis Hassabis. Protein complex prediction with AlphaFold-Multimer. bioRxiv (2022). https://doi.org/10.1101/2021.10.04.463034
25 Bisong, E. Building Machine Learning and Deep Learning Models on Google Cloud Platform: A Comprehensive Guide for Beginners., (2019).
26 Yan, R., Xu, D., Yang, J., Walker, S. & Zhang, Y. A comparative assessment and analysis of 20 representative sequence alignment methods for protein structure prediction. Sci Rep 3, 2619 (2013). https://doi.org/10.1038/srep02619
27 Jacobs-Cacha, C. et al. A misprocessed form of Apolipoprotein A-I is specifically associated with recurrent Focal Segmental Glomerulosclerosis. Sci Rep 10, 1159 (2020). https://doi.org/10.1038/s41598-020-58197-y
28 Gogonea, V. Structural Insights into High Density Lipoprotein: Old Models and New Facts. Front Pharmacol 6, 318 (2015). https://doi.org/10.3389/fphar.2015.00318
29 Morgunova, E., Tuuttila, A., Bergmann, U. & Tryggvason, K. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc Natl Acad Sci U S A 99, 7414-7419 (2002). https://doi.org/10.1073/pnas.102185399
30 Hashimoto, H. et al. Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of beta-amyloid precursor protein-derived inhibitor. J Biol Chem 286, 33236-33243 (2011). https://doi.org/10.1074/jbc.M111.264176
31 Newby, A. C. Metalloproteinases and vulnerable atherosclerotic plaques. Trends Cardiovasc Med 17, 253-258 (2007). https://doi.org/10.1016/j.tcm.2007.09.001
32 Olejarz, W., Lacheta, D. & Kubiak-Tomaszewska, G. Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability. Int J Mol Sci 21 (2020). https://doi.org/10.3390/ijms21113946
33 Florvall, G., Basu, S. & Larsson, A. Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men. J Gerontol A Biol Sci Med Sci 61, 1262-1266 (2006). https://doi.org/10.1093/gerona/61.12.1262
34 McQueen, M. J. et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 372, 224-233 (2008). https://doi.org/10.1016/S0140-6736(08)61076-4
35 Maddaluno, M. et al. Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation. Atherosclerosis 217, 113-119 (2011). https://doi.org/10.1016/j.atherosclerosis.2011.04.002
36 Manicone, A. M. & McGuire, J. K. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 19, 34-41 (2008). https://doi.org/10.1016/j.semcdb.2007.07.003
37 McQuibban, G. A. et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289, 1202-1206 (2000). https://doi.org/10.1126/science.289.5482.1202
38 de Jager, S. C. A. & Hoefer, I. E. Beyond the matrix: MMP2 as critical regulator of inflammation-mediated vascular dysfunction. Cardiovasc Res 113, 1705-1707 (2017). https://doi.org/10.1093/cvr/cvx202
39 Iyer, R. P., Patterson, N. L., Fields, G. B. & Lindsey, M. L. The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol 303, H919-930 (2012). https://doi.org/10.1152/ajpheart.00577.2012
40 Silver, D. L., Wang, N., Xiao, X. & Tall, A. R. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem 276, 25287-25293 (2001). https://doi.org/10.1074/jbc.M101726200